← Back

Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Price · split & dividend adjusted
News & notes moving ASH
ASH

Ashland board declares $0.42 quarterly cash dividend

Ashland Inc.'s board of directors has declared a quarterly cash dividend of $0.42 per share on its common stock. The dividend is payable on September 15, 2026, to stockholders of record as of the close of business on September 1, 2026. As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding.
GlobeNewswire·19dRead more ▾
ASH

Ashland reports third quarter 2026 sales of $497 million, reaffirms full-year outlook

Ashland Inc. reported third quarter fiscal 2026 sales of $497 million, up seven percent from the prior-year quarter, and reaffirmed its full-year sales and Adjusted EBITDA guidance. Income from continuing operations was $41 million, or $0.89 per diluted share, while Adjusted EBITDA declined four percent to $109 million. Sales volumes rose six percent across all business units, with Life Sciences and Personal Care driving growth, though lower Specialty Additives and Intermediates earnings weighed on profitability. The company reaffirmed its fiscal 2026 sales outlook of $1,835 to $1,870 million and Adjusted EBITDA of $385 to $400 million, while revising adjusted EPS growth expectations to low-to-mid single digits due to a higher tax rate.
GlobeNewswire·29dRead more ▾
ASH

Ashland nears settlement with activist Ancora Holdings

Ashland Inc. is nearing an agreement with activist investor Ancora Holdings that would expand the chemical maker's board. Under the settlement, two directors will be added to the board and a capital allocation committee will be created, according to a Bloomberg report citing people familiar with the matter. The settlement may be announced as soon as Tuesday. The news follows reports that Ancora disclosed a significant stake and wants the company to pursue a sales process, believing Ashland could see at least $76 a share in a sale. Shares of Ashland rose 3.2% on Tuesday.
Seeking Alpha·29dRead more ▾
ASH

Ashland sets July 29 webcast for third-quarter fiscal 2026 earnings

Ashland Inc. announced it will release its third-quarter fiscal 2026 earnings on Tuesday, July 28, 2026, at approximately 5 p.m. Eastern Time, followed by a live webcast for securities analysts on Wednesday, July 29, at 9 a.m. Eastern Time. The webcast will feature an executive summary and detailed remarks from chair and CEO Guillermo Novo, CFO William Whitaker, and other senior leaders. A slide presentation will be posted in the Investor Relations section of the company’s website simultaneously with the webcast. An archived version of the webcast and supporting materials will be available for 12 months after the live event.
GlobeNewswire·43dRead more ▾
ASH

Marine collagen market projected to reach USD 1.66 billion by 2031

The global marine collagen market is projected to grow from USD 1.14 billion in 2026 to USD 1.66 billion by 2031, at a compound annual growth rate of 6.7%. The liquid segment leads this growth, valued for its convenient and fast absorption benefits. Predominantly sourced from fish skin, scales, and muscles, marine collagen's nutritional products segment dominates, driven by its health benefits for skin, joints, and bones. Asia Pacific leads the market due to its abundant marine resources and rising demand for collagen-based nutraceuticals and cosmetics. Key players include Ashland, Darling Ingredients, Weishardt, and Nitta Gelatin.
ResearchAndMarkets.com·52dRead more ▾